Clinical Trial: A Two-armed Real-world Study of Ozempic (OW Semaglutide) to Evaluate Its Adherence and Persistence Compared With Other Anti-diabetic Drugs Among Adult T2DM Patients in China

U.S., March 7 -- ClinicalTrials.gov registry received information related to the study (NCT07456774) titled 'A Two-armed Real-world Study of Ozempic (OW Semaglutide) to Evaluate Its Adherence and Persistence Compared With Other Anti-diabetic Drugs Among Adult T2DM Patients in China' on Feb. 09.

Brief Summary: The study is testing the incidence of MACE and incidence of renal events between Ozempic(R) users and users with other anti-diabetic medications in T2D patients. This is a retrospective study, and participants had received Ozempic or any other anti-diabetic medications.

Study Start Date: Feb. 13

Study Type: OBSERVATIONAL

Condition: Type 2 Diabetes

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Novo Nordisk A/S

Published by HT ...